Literature DB >> 2139906

Circulating immune complexes in HIV-infected persons.

F E Krapf1, M Herrmann, W Leitmann, B Schwartländer, J R Kalden.   

Abstract

Circulating immune complexes are part of normal immune defense mechanisms and, therefore, present in various infectious--bacterial and viral--diseases. On the other hand, they are obviously involved in pathogenic mechanisms, e.g., autoimmune diseases or different forms of malignancies. Both autoimmune and infectious features are recorded in the acquired immunodeficiency syndrome. Thus, elevated levels of antigen-antibody complexes in HIV-infected persons had to be expected, and they were in fact demonstrated by several authors. In a cohort study, it was additionally shown that circulating immune complexes are of prognostic relevance. After an introduction concerning the physiological and pathophysiological role of circulating immune complexes in general, their involvement in the course of HIV infections is presented and discussed. In addition, there is a critical review of the most commonly applied assay systems for the detection and quantification of circulating immune complexes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2139906     DOI: 10.1007/bf01649020

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  21 in total

1.  The Fc and not CD4 receptor mediates antibody enhancement of HIV infection in human cells.

Authors:  J Homsy; M Meyer; M Tateno; S Clarkson; J A Levy
Journal:  Science       Date:  1989-06-16       Impact factor: 47.728

2.  Detection and partial characterization of circulating immune complexes with solid-phase anti-C3.

Authors:  A B Pereira; A N Theofilopoulos; F J Dixon
Journal:  J Immunol       Date:  1980-08       Impact factor: 5.422

3.  Use and abuse of laboratory tests in clinical immunology: critical considerations of eight widely used diagnostic procedures. Report of a joint IUIS/WHO meeting on assessment of tests used in clinical immunology.

Authors: 
Journal:  Clin Immunol Immunopathol       Date:  1982-07

Review 4.  Immune complexes suppress cellular immunity.

Authors:  H W Virgin; E R Unanue
Journal:  Ann N Y Acad Sci       Date:  1984       Impact factor: 5.691

5.  A PEG-precipitation laser nephelometer technique for detection and characterization of circulating immune complexes in human sera.

Authors:  F Krapf; D Renger; I Schedel; K Leiendecker; H Leyssens; H Deicher
Journal:  J Immunol Methods       Date:  1982-10-15       Impact factor: 2.303

6.  Determination of complement activating circulating immune complexes and an example for antigen specific immune complex assays.

Authors:  F Krapf; C Fuchs; M Herrmann; S Hoferichter; J R Kalden
Journal:  J Clin Lab Immunol       Date:  1986-12

7.  Colorectal carcinoma. Evidence for circulating CEA-anti-CEA complexes.

Authors:  G M Mavligit; S Stuckey
Journal:  Cancer       Date:  1983-07-01       Impact factor: 6.860

8.  Immune complexes in the acquired immunodeficiency syndrome (AIDS): relationship to disease manifestation, risk group, and immunologic defect.

Authors:  J S McDougal; M Hubbard; J K Nicholson; B M Jones; R C Holman; J Roberts; D B Fishbein; H W Jaffe; J E Kaplan; T J Spira
Journal:  J Clin Immunol       Date:  1985-03       Impact factor: 8.317

9.  Relation of circulating levels of human immunodeficiency virus (HIV) antigen, antibody to p24, and HIV-containing immune complexes in HIV-infected patients.

Authors:  T M McHugh; D P Stites; M P Busch; J F Krowka; R B Stricker; H Hollander
Journal:  J Infect Dis       Date:  1988-11       Impact factor: 5.226

10.  Demonstration of HBsAg as the antigen component in circulating immune complexes detected by peg-solid phase test.

Authors:  D E Sansonno; P Detomaso; M V Primavera; M A Papanice; R Donnaloia; O G Manghisi
Journal:  J Virol Methods       Date:  1986-09       Impact factor: 2.014

View more
  5 in total

1.  The size and composition of circulating immune complexes during HIV infection.

Authors:  L B Korolevskaya; K V Shmagel; N G Shmagel; V A Chereshnev
Journal:  Dokl Biochem Biophys       Date:  2014-08-30       Impact factor: 0.788

2.  Immunoglobulin and complement complexes in blood following infection with human immunodeficiency virus type 1.

Authors:  X X Peng; M A Wainberg; Y Tao; B G Brenner
Journal:  Clin Diagn Lab Immunol       Date:  1996-01

3.  Aortic endothelium in HIV-1 infection: chronic injury, activation, and increased leukocyte adherence.

Authors:  C Zietz; B Hotz; M Stürzl; E Rauch; R Penning; U Löhrs
Journal:  Am J Pathol       Date:  1996-12       Impact factor: 4.307

4.  Phenotypic and functional changes in peripheral blood monocytes during progression of human immunodeficiency virus infection. Effects of soluble immune complexes, cytokines, subcellular particulates from apoptotic cells, and HIV-1-encoded proteins on monocytes phagocytic function, oxidative burst, transendothelial migration, and cell surface phenotype.

Authors:  J Trial; H H Birdsall; J A Hallum; M L Crane; M C Rodriguez-Barradas; A L de Jong; B Krishnan; C E Lacke; C G Figdor; R D Rossen
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

5.  Slow turnover of HIV-1 receptors on quiescent CD4+ T cells causes prolonged surface retention of gp120 immune complexes in vivo.

Authors:  Yasuhiro Suzuki; Hiroyuki Gatanaga; Natsuo Tachikawa; Shinichi Oka
Journal:  PLoS One       Date:  2014-02-06       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.